More than 200 Immunoglobulin (Ig) nurses and health care professionals gained fresh insights into the clinical practice of Ig therapy at the IgNS 1st National Conference, August 3-5th, 2012 at the Loews Portofino Bay Hotel in Orlando, FL.
Los Angeles, CA (PRWEB) August 08, 2012
More than 200 Immunoglobulin nurses and health care professionals gained fresh insights into the clinical practice of immunoglobulin therapy at the Immunoglobulin Nursing Society 1st National Conference, August 3-5th, 2012 at the Loews Portofino Bay Hotel in Orlando, FL.
The conference program featured a wide range of educational sessions on Immunoglobulin therapy, immunodeficiency, peripheral neuropathy, immune myopathy, along with updates on clinical trials and advocacy issues, presented by leading nurses, physicians and patient advocates. Attendees engaged in advancing their practice skills at Intravenous and Subcutaneous Immunoglobulin workshops. The latest updates in Immunoglobulin nursing practice and research were presented at the poster session.
IgNS President Jane Kirmse RN, MSN, APRN-BC welcomed attendees to the conference, and presented the results of the IgNS National Registry survey, which underscored the acute need for specialized education and live, hands-on training for Immunoglobulin nurses. This first registry of its kind, serves a dual purpose of obtaining heretofore-unknown data regarding the scale of the Immunoglobulin nursing field, as well as the current status, trends, and needs in Immunoglobulin nursing education.
The Director of the National Institute of Nursing Research, Patricia A. Grady, PhD, RN, FAAN delivered the keynote address. Dr. Grady overviewed the Institute of Medicine recent consensus report on the future of nursing, discussed the vital skills for today™s nurses, as well as highlighted the importance of nurse training relative to research, improving evidence-based practice and patient outcomes, and health policy.
The IgNS National Conference is a unique, and much needed forum that offers in-depth education on the most current and relevant clinical topics, and in addition, provides nurses with tools to further enhance their clinical practice to provide optimal care to their patients, said Ms. Kirmse.
Attendees earned continuing nursing and pharmacy education contact hours, networked with colleagues, and met with exhibitors representing leading companies in the Immunoglobulin field. Major patient advocacy organizations were invited to exhibit at the conference, to expand nurses™ awareness of various patient programs and services. The conference concluded on Sunday, August 5th with the announcement of the IgNS 2nd National Conference on Sep 22-25, 2013 in Chicago, IL.
For more information about IgNS please visit http://www.ig-ns.org or contact the headquarters at 1-888-855-4443; e-mail:nurses(at)ig-ns(dot)org.